Polymorphisms in two DNA repair genes (XPD and XRCC1)--association with age related cataracts.
OBJECTIVE
Age related cataract is the leading cause of blindness in the world today. The association between DNA damage to the lens epithelium and the development of lens opacities has been reported in many studies. Polymorphisms of DNA repair enzymes may affect repair efficiency and thereby lead to the development of age related cataract.


METHODS
In this study, we aimed to determine the frequency of polymorphisms in two DNA repair enzyme genes, xeroderma pigmentosum complementation group (XPD) codon 312 and X-ray complementing group1 (XRCC1) codon 399, in a sample of 208 cataract patients (69 with cortical, 69 with nuclear and 70 with posterior sub capsular) and 151 sex and age matched healthy controls. XPD genotype was determined by Amplification Refractory Mutation System (ARMS) while XRCC1 was genotyped using the PCR-RFLP method.


RESULTS
There was a significant difference between frequencies for XPD-312 Asn/Asn genotype in cataract patients (21.6%) and healthy controls (13.2%; p=0.03, OR=1.97, 95% CI=1.06-3.63). Considering the types of cataract, XPD-312 Asn/Asn genotype was found to be significantly different in patients with cortical (29%) type in comparison to controls (13.2%; p=0.03, OR=2.39, 95% CI=1.11-5.12). No statistically significant difference was found for the genotypic and allelic distributions of the polymorphism in XRCC1. The MDR interaction analysis revealed weak synergism between the markers XPD-Asp312Asn and XRCC1-Arg399Gln contributing to cataract. It also showed that the AA genotype of XPD-Asp312Asn polymorphism when present in combination with the GA genotype of XRCC1-Arg399Gln had a fivefold and with AA had a fourfold risk for developing cataract.


CONCLUSIONS
The present study suggests that a polymorphism in XPD codon 312 may be associated with the development of maturity onset cataract. This is the first report on the association of XPD Asp312Asn polymorphism with maturity onset cataract.
Department of Genetics, Osmania University, Tarnaka, Hyderabad, A.P, India. padmatirunilai@gmail.com
G
G
Padma
M
M
Mamata
K Ravi Kumar
KR
Reddy
T
T
Padma
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging; D000483:Alleles; D016022:Case-Control Studies; D002386:Cataract / Q000235:genetics*; D003062:Codon; D004260:DNA Repair; D004268:DNA-Binding Proteins / Q000235:genetics*; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D016133:Polymerase Chain Reaction / Q000379:methods; D011110:Polymorphism, Genetic; D012150:Polymorphism, Restriction Fragment Length; D000076105:X-ray Repair Cross Complementing Protein 1; D051759:Xeroderma Pigmentosum Group D Protein / Q000235:genetics*
D003062:Codon; D004268:DNA-Binding Proteins; D000076105:X-ray Repair Cross Complementing Protein 1; C000619371:XRCC1 protein, human; D051759:Xeroderma Pigmentosum Group D Protein; C497292:ERCC2 protein, human
Toxicol Lett. 2001 Mar 31;120(1-3):269-80
11323185
Mol Vis. 2005 Apr 18;11:274-83
15851978
Science. 2001 Feb 16;291(5507):1284-9
11181991
Exp Biol Med (Maywood). 2002 Oct;227(9):671-82
12324649
Exp Eye Res. 2007 Sep;85(3):328-34
17637462
Free Radic Biol Med. 1999 Apr;26(7-8):1034-53
10232849
Mutat Res. 2005 Nov 11;579(1-2):22-36
16055157
Carcinogenesis. 2000 Apr;21(4):551-5
10753184
Invest Ophthalmol Vis Sci. 1998 Feb;39(2):344-50
9477992
Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2384-90
17164360
Exp Eye Res. 1995 May;60(5):483-93
7615014
Exp Eye Res. 1977 Feb;24(2):113-9
851489
Invest Ophthalmol Vis Sci. 2004 Jun;45(6):1916-21
15161858
Ophthalmic Res. 1982;14(3):160-6
7099535
Carcinogenesis. 2007 May;28(5):1087-93
17210993
Mutat Res. 1990 Jan;240(1):35-45
2152969
Pathophysiology. 2006 Aug;13(3):151-62
16765571
Invest Ophthalmol Vis Sci. 1998 Mar;39(3):544-52
9501865
Mutagenesis. 1991 Nov;6(6):495-9
1800897
Biosci Rep. 2001 Aug;21(4):537-63
11900326
Mutat Res. 2007 May 1;618(1-2):149-62
17292925
DNA Repair (Amst). 2005 Sep 28;4(10):1068-74
16054878
Cancer Res. 1999 Jun 1;59(11):2557-61
10363972
Mech Ageing Dev. 2003 Jan;124(1):27-32
12618003
Curr Eye Res. 1993 Sep;12(9):773-81
8261789
FASEB J. 1995 Sep;9(12):1173-82
7672510
Lancet. 2005 Feb 12-18;365(9459):599-609
15708105
J Theor Biol. 2006 Jul 21;241(2):252-61
16457852
Nucleic Acids Res. 1991 Oct 11;19(19):5444
1681511
Carcinogenesis. 2000 May;21(5):965-71
10783319
Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4661-70
16303963
Dev Ophthalmol. 2002;35:21-31
12061276
Carcinogenesis. 2007 Jun;28(6):1254-8
17264068